Gin Hwa Biotech Incorporation (TPEX:7806)

Market Cap	2.02B +26.3%
Revenue (ttm)	535.88M +5.4%
Net Income	55.70M -27.1%
EPS	1.98 -35.8%
Shares Out	32.25M
PE Ratio	31.57
Forward PE	n/a
Dividend	0.95 (1.52%)
Ex-Dividend Date	Jul 27, 2026

Volume	28,329
Open	62.80
Previous Close	62.80
Day's Range	62.40 - 63.00
52-Week Range	55.50 - 77.62
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About TPEX:7806

Gin Hwa Biotech Incorporation manufactures and sells health supplements in Taiwan. The company offers nutritional supplements in various dosage forms, including soft gel encapsulations, tablets, capsules, liquids/ointments, powders, drop extracts, ready-to-drink, liquid sachets, pop rocks, tea bags, powder blends, ampoules, jellies, and other formats. Its products contain neuroboost, myorenew, dermaessence, cranbliss, and glycobalance ingredients. Gin Hwa Biotech Incorporation was founded in 2019 and is based in Kaohsiung, Taiwan.

• Industry: Pharmaceutical Preparations
• Founded: 2019
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 7806

Financial Performance

In 2025, TPEX:7806's revenue was 538.65 million, an increase of 23.80% compared to the previous year's 435.08 million. Earnings were 75.33 million, an increase of 12.85%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 28, 2026

Data Sources Report a data error